Last 12 months
Inside the activity.
7 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 5 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2023 Filed Feb 17, 2023 21:15 UTC |
Bookman MichaelGENERAL COUNSEL AND SECRETARY
|
GrantStock Option · Derivative | 143,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001415889-23-002755 · form4-02172023_040202.xml · derivative · entry 1 Bookman Michael · CIK 0001840339 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,000 Underlying: Class A Common Stock · 143,000 shares Expires 2033-02-15 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027. Read SEC document |
| December 22, 2022 Filed Dec 27, 2022 13:14 UTC |
Zeskind Benjamin J.Director · PRESIDENT AND CEO · 10% owner
|
Exercise / conversionStock Option · Derivative | 2,500 | $0.00 Strike: $3.01 | $0.00 |
DisclosureSEC source: 0001415889-22-012975 · form4-12272022_011215.xml · derivative · entry 3 Zeskind Benjamin J. · CIK 0001870062 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,500 Underlying: Class A Common Stock · 2,500 shares Expires 2029-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option has fully vested and is currently exercisable. Read SEC document |
| December 22, 2022 Filed Dec 27, 2022 13:14 UTC |
Zeskind Benjamin J.Director · PRESIDENT AND CEO · 10% owner
|
Exercise / conversionClass A Common Stock | 2,500 | $3.01 | $7,525.00 |
DisclosureSEC source: 0001415889-22-012975 · form4-12272022_011215.xml · nonDerivative · entry 1 Zeskind Benjamin J. · CIK 0001870062 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,261,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 13:03 UTC |
Neufeld Leah RCHIEF PEOPLE OFFICER
|
GrantStock Option · Derivative | 88,600 | $0.00 Strike: $13.85 | $0.00 |
DisclosureSEC source: 0001415889-22-010973 · form4-11022022_061118.xml · derivative · entry 1 Neufeld Leah R · CIK 0001950673 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,600 Underlying: Class A Common Stock · 88,600 shares Expires 2032-10-31 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on October 17, 2023 and then in equal monthly installments over the subsequent three years, subject to Ms. Neufeld's continued employment through each applicable vesting date. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:15 UTC |
Morales MalloryVICE PRESIDENT, FINANCE
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $6.33 | $0.00 |
DisclosureSEC source: 0001415889-22-008536 · form4-08122022_040801.xml · derivative · entry 1 Morales Mallory · CIK 0001941795 · VICE PRESIDENT, FINANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires 2032-08-11 F1 · derivative.exercise_date: 100% of the option vests and becomes exercisable on August 11, 2023, subject Ms. Morales' continued employment through such date. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 21:00 UTC |
CARPENTER ROBERT JDirector
|
GrantStock Option · Derivative | 14,200 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001415889-22-006898 · form4-06232022_020624.xml · derivative · entry 1 CARPENTER ROBERT J · CIK 0001021046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,200 Underlying: Class A Common Stock · 14,200 shares Expires 2032-06-20 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 21, 2022, and will be fully vested and exercisable on June 21, 2023, or the date of the 2023 annual meeting of stockholders, whichever comes first. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 21:06 UTC |
Feinberg PeterDirector
|
GrantStock Option · Derivative | 14,200 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001415889-22-006899 · form4-06232022_020630.xml · derivative · entry 1 Feinberg Peter · CIK 0001870076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,200 Underlying: Class A Common Stock · 14,200 shares Expires 2032-06-20 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 21, 2022, and will be fully vested and exercisable on June 21, 2023, or the date of the 2023 annual meeting of stockholders, whichever comes first. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:59 UTC |
KEATING LAURIEDirector
|
GrantStock Option · Derivative | 14,200 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001415889-22-006897 · form4-06232022_010649.xml · derivative · entry 1 KEATING LAURIE · CIK 0001620743 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,200 Underlying: Class A Common Stock · 14,200 shares Expires 2032-06-20 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 21, 2022, and will be fully vested and exercisable on June 21, 2023, or the date of the 2023 annual meeting of stockholders, whichever comes first. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 17:08 UTC |
BERMAN ANN EDirector
|
GrantStock Option · Derivative | 14,200 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001415889-22-006900 · form4-06232022_020628.xml · derivative · entry 1 BERMAN ANN E · CIK 0001349408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,200 Underlying: Class A Common Stock · 14,200 shares Expires 2032-06-20 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 21, 2022, and will be fully vested and exercisable on June 21, 2023, or the date of the 2023 annual meeting of stockholders, whichever is earlier. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:56 UTC |
HAUSMAN DIANADirector
|
GrantStock Option · Derivative | 6,185 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001415889-22-006896 · form4-06232022_010613.xml · derivative · entry 1 HAUSMAN DIANA · CIK 0001563992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,185 Underlying: Class A Common Stock · 6,185 shares Expires 2032-06-20 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 21, 2022, and will be fully vested and exercisable on June 21, 2023, or the date of the 2023 annual meeting of stockholders, whichever comes first. Read SEC document |
| May 25, 2022 Filed May 27, 2022 20:09 UTC |
Hall Brett MatthewCHIEF SCIENTIFIC OFFICER
|
PurchaseClass A Common Stock | 2,551 | $3.92 | $9,999.92 |
DisclosureSEC source: 0001415889-22-005796 · form4-05272022_010532.xml · nonDerivative · entry 1 Hall Brett Matthew · CIK 0001870437 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,685 Read SEC document |
| May 17, 2022 Filed May 18, 2022 23:28 UTC |
Bookman MichaelGENERAL COUNSEL AND SECRETARY
|
PurchaseClass A Common Stock | 1,000 | $4.88 | $4,880.00 |
DisclosureSEC source: 0001415889-22-005253 · form4-05182022_040523.xml · nonDerivative · entry 1 Bookman Michael · CIK 0001840339 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,402 Read SEC document |
| May 16, 2022 Filed May 17, 2022 21:15 UTC |
KEATING LAURIEDirector
|
PurchaseClass A Common Stock | 7,000 | $5.00 | $35,000.00 |
DisclosureSEC source: 0001415889-22-005150 · form4-05172022_020524.xml · nonDerivative · entry 1 KEATING LAURIE · CIK 0001620743 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Read SEC document |
| May 12, 2022 Filed May 12, 2022 17:37 UTC |
Amin BirenCFO, TREASURER
|
PurchaseClass A Common Stock | 1,000 | $4.42 | $4,420.00 |
DisclosureSEC source: 0001415889-22-004919 · form4-05122022_020511.xml · nonDerivative · entry 1 Amin Biren · CIK 0001870127 · CFO, TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,898 Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:30 UTC |
Zeskind Benjamin J.Director · PRESIDENT AND CEO · 10% owner
|
Exercise / conversionStock Option · Derivative | 2,000 | $0.00 Strike: $3.01 | $0.00 |
DisclosureSEC source: 0001415889-22-004065 · form4-04142022_010428.xml · derivative · entry 3 Zeskind Benjamin J. · CIK 0001870062 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,000 Underlying: Class A Common Stock · 2,000 shares Expires 2029-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option has fully vested and is currently exercisable. Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:30 UTC |
Zeskind Benjamin J.Director · PRESIDENT AND CEO · 10% owner
|
Exercise / conversionClass A Common Stock | 2,000 | $3.01 | $6,020.00 |
DisclosureSEC source: 0001415889-22-004065 · form4-04142022_010428.xml · nonDerivative · entry 1 Zeskind Benjamin J. · CIK 0001870062 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,259,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2022 Filed Mar 23, 2022 22:38 UTC |
Hall Brett MatthewCHIEF SCIENTIFIC OFFICER
|
PurchaseClass A Common Stock | 1,050 | $7.91 | $8,305.50 |
DisclosureSEC source: 0001415889-22-003305 · form4-03232022_030347.xml · nonDerivative · entry 1 Hall Brett Matthew · CIK 0001870437 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,134 Read SEC document |
| March 23, 2022 Filed Mar 24, 2022 20:39 UTC |
Zeskind Benjamin J.Director · PRESIDENT AND CEO · 10% owner
|
PurchaseClass A Common Stock | 3,000 | $8.02 | $24,060.00 |
DisclosureSEC source: 0001415889-22-003324 · form4-03242022_010305.xml · nonDerivative · entry 1 Zeskind Benjamin J. · CIK 0001870062 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,257,352 F1 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $7.92 to $8.10. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price. Read SEC document |
| March 22, 2022 Filed Mar 22, 2022 18:49 UTC |
Barrett ScottCHIEF MEDICAL OFFICER
|
PurchaseClass A Common Stock | 900 | $7.49 | $6,736.50 |
DisclosureSEC source: 0001415889-22-003270 · form4-03222022_030337.xml · nonDerivative · entry 1 Barrett Scott · CIK 0001869953 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,563 F1 · price: This transaction was executed in multiple trades through a broker-dealer. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price. Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 17:53 UTC |
BERMAN ANN EDirector
|
PurchaseClass A Common Stock | 6,000 | $6.40 | $38,400.00 |
DisclosureSEC source: 0001415889-22-002974 · form4-03152022_020312.xml · nonDerivative · entry 1 BERMAN ANN E · CIK 0001349408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 F1 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $6.35 to $6.45. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 21:30 UTC |
Feinberg PeterDirector
|
PurchaseClass A Common Stock | 6,667 | $6.75 | $45,002.25 |
DisclosureSEC source: 0001415889-22-003061 · form4-03162022_020302.xml · nonDerivative · entry 1 Feinberg Peter · CIK 0001870076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,766 F1 · price: This transaction was executed in multiple trades through a broker-dealer at a price of $6.75. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at such price. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 22:19 UTC |
Zeskind Benjamin J.Director · PRESIDENT AND CEO · 10% owner
|
Exercise / conversionStock Option · Derivative | 2,000 | $0.00 Strike: $3.01 | $0.00 |
DisclosureSEC source: 0001415889-22-002061 · form4-03012022_020328.xml · derivative · entry 3 Zeskind Benjamin J. · CIK 0001870062 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,000 Underlying: Class A Common Stock · 2,000 shares Expires 2029-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option has fully vested and is currently exercisable. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 22:19 UTC |
Zeskind Benjamin J.Director · PRESIDENT AND CEO · 10% owner
|
Exercise / conversionClass A Common Stock | 2,000 | $3.01 | $6,020.00 |
DisclosureSEC source: 0001415889-22-002061 · form4-03012022_020328.xml · nonDerivative · entry 1 Zeskind Benjamin J. · CIK 0001870062 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,254,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:27 UTC |
Zeskind Benjamin J.Director · PRESIDENT AND CEO · 10% owner
|
GrantStock Option · Derivative | 45,615 | $0.00 Strike: $10.63 | $0.00 |
DisclosureSEC source: 0001415889-22-001324 · form4-02142022_020219.xml · derivative · entry 2 Zeskind Benjamin J. · CIK 0001870062 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,100 Underlying: Class A Common Stock · 45,615 shares Expires 2027-02-09 F2 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:27 UTC |
Zeskind Benjamin J.Director · PRESIDENT AND CEO · 10% owner
|
GrantStock Option · Derivative | 156,485 | $0.00 Strike: $9.66 | $0.00 |
DisclosureSEC source: 0001415889-22-001324 · form4-02142022_020219.xml · derivative · entry 1 Zeskind Benjamin J. · CIK 0001870062 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,485 Underlying: Class A Common Stock · 156,485 shares Expires 2032-02-09 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 17:35 UTC |
Amin BirenCFO, TREASURER
|
GrantStock Option · Derivative | 70,050 | $0.00 Strike: $9.66 | $0.00 |
DisclosureSEC source: 0001415889-22-001330 · form4-02142022_020254.xml · derivative · entry 1 Amin Biren · CIK 0001870127 · CFO, TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,050 Underlying: Class A Common Stock · 70,050 shares Expires 2032-02-09 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 17:32 UTC |
Barrett ScottCHIEF MEDICAL OFFICER
|
GrantStock Option · Derivative | 71,850 | $0.00 Strike: $9.66 | $0.00 |
DisclosureSEC source: 0001415889-22-001326 · form4-02142022_020230.xml · derivative · entry 1 Barrett Scott · CIK 0001869953 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,850 Underlying: Class A Common Stock · 71,850 shares Expires 2032-02-09 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:29 UTC |
Bookman MichaelGENERAL COUNSEL AND SECRETARY
|
GrantStock Option · Derivative | 47,300 | $0.00 Strike: $9.66 | $0.00 |
DisclosureSEC source: 0001415889-22-001325 · form4-02142022_020236.xml · derivative · entry 1 Bookman Michael · CIK 0001840339 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,300 Underlying: Class A Common Stock · 47,300 shares Expires 2032-02-09 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:33 UTC |
Hall Brett MatthewCHIEF SCIENTIFIC OFFICER
|
GrantStock Option · Derivative | 83,100 | $0.00 Strike: $9.66 | $0.00 |
DisclosureSEC source: 0001415889-22-001329 · form4-02142022_020226.xml · derivative · entry 1 Hall Brett Matthew · CIK 0001870437 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,100 Underlying: Class A Common Stock · 83,100 shares Expires 2032-02-09 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026. Read SEC document |
| January 14, 2022 Filed Jan 18, 2022 13:21 UTC |
HAUSMAN DIANADirector
|
GrantStock Option · Derivative | 25,200 | $13.00 Strike: $13.00 | $327,600.00 |
DisclosureSEC source: 0001415889-22-000586 · form4-01182022_050138.xml · derivative · entry 1 HAUSMAN DIANA · CIK 0001563992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,200 Underlying: Class A Common Stock · 25,200 shares Expires 2032-01-13 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a three year period commencing on February 14, 2022, and will be fully vested and exercisable on January 14, 2025. Read SEC document |
| December 22, 2021 Filed Dec 22, 2021 22:30 UTC |
Hall Brett MatthewCHIEF SCIENTIFIC OFFICER
|
GrantClass A Common Stock | 322,691 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-006188 · form4-12222021_021254.xml · nonDerivative · entry 1 Hall Brett Matthew · CIK 0001870437 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,084 F1 · price: Calculated using a value based on the average of the daily volume weighted average prices of the Class A common stock on the Nasdaq Stock Exchange for the 30-trading day period ending on and including the trading day immediately prior to the Closing Date, as that term is defined in the Share Purchase Agreement, dated as of December 22, 2021, by and among Immuneering Corporation, BioArkive, Inc. ("BioArkive"), and each of the shareholders of BioArkive, including Dr. Hall. Read SEC document |
| October 22, 2021 Filed Feb 10, 2022 21:29 UTC |
Zeskind Benjamin J.Director · PRESIDENT AND CEO · 10% owner
|
GiftClass A Common Stock | 350,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-001194 · form5-02102022_010236.xml · nonDerivative · entry 2 Zeskind Benjamin J. · CIK 0001870062 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Foonote Disclosed balance after: 894,927 F1 · ownership.nature: Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee. Read SEC document |
| October 22, 2021 Filed Feb 10, 2022 21:29 UTC |
Zeskind Benjamin J.Director · PRESIDENT AND CEO · 10% owner
|
GiftClass A Common Stock | 350,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-001194 · form5-02102022_010236.xml · nonDerivative · entry 1 Zeskind Benjamin J. · CIK 0001870062 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,252,352 Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 21:53 UTC |
Feinberg PeterDirector
|
PurchaseClass A Common Stock | 4,750 | $24.45 | $116,113.75 |
DisclosureSEC source: 0001415889-21-004512 · form4-09212021_020937.xml · nonDerivative · entry 1 Feinberg Peter · CIK 0001870076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,099 F1 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.75 to $24.75. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 20:47 UTC |
Zeskind Benjamin J.Director · PRESIDENT AND CEO · 10% owner
|
PurchaseClass A Common Stock | 2,083 | $22.87 | $47,631.96 |
DisclosureSEC source: 0001415889-21-004382 · form4-09142021_010944.xml · nonDerivative · entry 1 Zeskind Benjamin J. · CIK 0001870062 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,602,352 F1 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $22.41 to $23.375. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:58 UTC |
Feinberg PeterDirector
|
PurchaseClass A Common Stock | 349 | $21.25 | $7,416.25 |
DisclosureSEC source: 0001415889-21-004407 · form4-09152021_020922.xml · nonDerivative · entry 2 Feinberg Peter · CIK 0001870076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349 F2 · price: This transaction was executed in multiple trades through a broker-dealer at a price of $21.25. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:58 UTC |
Feinberg PeterDirector
|
PurchaseClass A Common Stock | 5,750 | $21.51 | $123,697.45 |
DisclosureSEC source: 0001415889-21-004407 · form4-09152021_020922.xml · nonDerivative · entry 1 Feinberg Peter · CIK 0001870076 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · General Partner of PF Associates L.P. Disclosed balance after: 392,242 F1 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.08 to $22.00. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 10:05 UTC |
CARPENTER ROBERT JDirector
|
ConversionSeries B Preferred Stock · Derivative | 122,588 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-099732 · tm2123807-5_4seq.xml · derivative · entry 4 CARPENTER ROBERT J · CIK 0001021046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 122,588 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 10:05 UTC |
CARPENTER ROBERT JDirector
|
ConversionSeries A Preferred Stock · Derivative | 94,585 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-099732 · tm2123807-5_4seq.xml · derivative · entry 3 CARPENTER ROBERT J · CIK 0001021046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 94,585 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 10:05 UTC |
CARPENTER ROBERT JDirector
|
PurchaseClass A Common Stock | 325,000 | $15.00 | $4,875,000.00 |
DisclosureSEC source: 0001104659-21-099732 · tm2123807-5_4seq.xml · nonDerivative · entry 2 CARPENTER ROBERT J · CIK 0001021046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,148,839 Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 10:05 UTC |
CARPENTER ROBERT JDirector
|
ConversionClass A Common Stock | 217,173 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-099732 · tm2123807-5_4seq.xml · nonDerivative · entry 1 CARPENTER ROBERT J · CIK 0001021046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 823,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 10:06 UTC |
Zeskind Benjamin J.Director · President and CEO · 10% owner
|
ConversionSeries B Preferred Stock · Derivative | 8,171 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-099741 · tm2123807-8_4seq1.xml · derivative · entry 5 Zeskind Benjamin J. · CIK 0001870062 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 8,171 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 10:06 UTC |
Zeskind Benjamin J.Director · President and CEO · 10% owner
|
ConversionSeries A Preferred Stock · Derivative | 40,928 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-099741 · tm2123807-8_4seq1.xml · derivative · entry 4 Zeskind Benjamin J. · CIK 0001870062 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 40,928 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 10:06 UTC |
Zeskind Benjamin J.Director · President and CEO · 10% owner
|
PurchaseClass A Common Stock | 2,098 | $15.00 | $31,470.00 |
DisclosureSEC source: 0001104659-21-099741 · tm2123807-8_4seq1.xml · nonDerivative · entry 2 Zeskind Benjamin J. · CIK 0001870062 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600,269 Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 10:06 UTC |
Zeskind Benjamin J.Director · President and CEO · 10% owner
|
ConversionClass A Common Stock | 49,099 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-099741 · tm2123807-8_4seq1.xml · nonDerivative · entry 1 Zeskind Benjamin J. · CIK 0001870062 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,598,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 06:04 UTC |
Amin BirenCFO, Treasurer
|
ConversionSeries B Preferred Stock · Derivative | 2,723 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-099723 · tm2123807-1_4seq1.xml · derivative · entry 3 Amin Biren · CIK 0001870127 · CFO, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,723 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 06:04 UTC |
Amin BirenCFO, Treasurer
|
PurchaseClass A Common Stock | 4,175 | $15.00 | $62,625.00 |
DisclosureSEC source: 0001104659-21-099723 · tm2123807-1_4seq1.xml · nonDerivative · entry 2 Amin Biren · CIK 0001870127 · CFO, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,898 Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 06:04 UTC |
Amin BirenCFO, Treasurer
|
ConversionClass A Common Stock | 2,723 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-099723 · tm2123807-1_4seq1.xml · nonDerivative · entry 1 Amin Biren · CIK 0001870127 · CFO, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 06:04 UTC |
Barrett ScottChief Medical Officer
|
ConversionSeries B Preferred Stock · Derivative | 2,723 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-099725 · tm2123807-2_4seq1.xml · derivative · entry 4 Barrett Scott · CIK 0001869953 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,723 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 06:04 UTC |
Barrett ScottChief Medical Officer
|
ConversionSeries A Preferred Stock · Derivative | 3,273 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-099725 · tm2123807-2_4seq1.xml · derivative · entry 3 Barrett Scott · CIK 0001869953 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,273 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.